Treatment Decisions in Non–Small Cell Lung Cancer
This publication highlights insights from expert stakeholders on the evolving therapeutic landscape of immunotherapy-based treatment regimens through a review of clinical scenarios of patients with non-small cell lung cancer.
EP: 1.Dr. Leal on the Utilization of PD-1/PD-L1 Inhibitor Monotherapy in Lung Cancer
EP: 2.Dr. Socinski on Treatment Considerations for Difficult-to-Treat Patients in Lung Cancer
EP: 3.Dr. Santos on the Utilization of Approved Monotherapies in NSCLC
Now Viewing
EP: 4.Treatment Decisions in Non–Small Cell Lung Cancer
Related Videos
Related Content
